logo
ResearchBunny Logo
Randomised controlled trials for mpox in endemic countries

Biology

Randomised controlled trials for mpox in endemic countries

K. Uriu, J. Ito, et al.

Discover the groundbreaking findings on the SARS-CoV-2 Omicron XBB.1.5 variant, which showcases significantly enhanced ACE2 receptor binding and remarkable resistance to neutralizing antibodies. Conducted by a team of esteemed researchers from various institutions, this study sheds light on the variant's rapid global spread and its ability to evade immune responses.... show more
Abstract
Publisher
The Lancet Infectious Diseases
Published On
Jan 01, 2023
Authors
Keiya Uriu, Jumpei Ito, Jiri Zahradnik, Shigeru Fujita, Yusuke Kosugi, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato
Tags
SARS-CoV-2
Omicron XBB.1.5
ACE2 receptor
neutralizing antibodies
virus transmissibility
virological features
antibody evasion
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny